Nathan Cheng (@realNathanCheng), program director for On Deck Longevity, joins Erik on this episode to discuss:- The key breakthroughs in aging research in the past.- Why we're still waiting for the first success story in humans, and why he predicts the first drug will be approved in the next ten years.- Why the space has plenty of capital but not enough founders.- The challenges and roadblocks in the space.- Common misconceptions about longevity.- Who should think about applying to the program.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at www.villageglobal.vc or get in touch with us on Twitter @villageglobal.Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. www.villageglobal.vc/signup